tetraphenylphosphonium has been researched along with Cardiomyopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjork, JA; Froberg, MK; Leino, RL; Moreno, AJ; Oliveira, PJ; Santos, MS; Wallace, KB | 1 |
1 other study(ies) available for tetraphenylphosphonium and Cardiomyopathies
Article | Year |
---|---|
Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
Topics: Adrenergic beta-Antagonists; Animals; Antibiotics, Antineoplastic; Antioxidants; Calcium; Carbazoles; Cardiomyopathies; Carvedilol; Cell Surface Extensions; Doxorubicin; Glutathione Peroxidase; Glutathione Reductase; Ion Channels; Male; Microscopy, Electron; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Onium Compounds; Organophosphorus Compounds; Oxygen Consumption; Propanolamines; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2004 |